Bruckaya, Kucherenko and Sorokina (VNIIMS, Uglich) tested six collection lactobacilli against a single E. coli VKVM-125 collection strain using three complementary in vitro assays: perpendicular streaks on MRS agar, co-cultivation in sterile skim milk, and neutralized cell-free metabolites (0.22 Β΅m filtered, pH 6.5 Β± 0.1), with triplicate experiments and P = 0.95 statistical processing .
All six strains produced inhibition zones (8.0β12.0 mm); L. plantarum 28 and 37 were strongest at 12.0 and 11.7 mm . Notably, the authors report that the largest zone did not track acidification: L. plantarum 28 had the lowest acidifying activity (pH 5.71 at 48 h) yet the largest zone β an internally honest observation supporting a non-acid mechanism.
No significant suppression appeared in the first 24 h. By 48 h, L. rhamnosus P cut viable E. coli by ~4 log, nearly eliminating it by 72 h; L. casei 738-11 and L. paracasei K-6 gave 6-log reductions by 72 h despite only 7.2% and 11.9% reductions at 48 h; L. plantarum 28 gave 3.4 log at 72 h. Death rates from 48β72 h were 0.02 hβ»ΒΉ (control), 0.14 hβ»ΒΉ (L. plantarum 28), 0.13 hβ»ΒΉ (L. rhamnosus P), 0.22 hβ»ΒΉ (L. paracasei K-6), 0.23 hβ»ΒΉ (L. casei 738-11) .
Neutralized L. rhamnosus P metabolites suppressed E. coli dose-dependently (10% > 5% > 1%), which the authors interpret as evidence of specific antagonistic substances beyond pH effects . BGPT inference: this is the weakest link β dose-response with a neutralized MRS-derived supernatant does not exclude residual organic acids buffering effects, HβOβ degradation products, or unidentified metabolites; the specific compound was never identified, and evidence is shown only for one of six strains.
A modest, methodologically transparent screening study with internally consistent data and honest limitations. The three-assay triangulation is its main strength; the single test strain, missing statistics, absent mechanistic identification, and lack of in-situ confirmation mean the "protective starter" application remains a hypothesis, not a demonstrated outcome. Confidence: moderate β findings are internally supported but generalization beyond VKVM-125 and MRS/milk systems is uncertain; falsified if zone-assay artifacts or multi-strain coliform resistance emerge.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.